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In the last twenty years, advanced magnetic resonance imag-
ing(MRI)techniqueshaveprovidedfundamentalknowledge
about neurodegenerative processes underlying several neu-
rological and psychiatric diseases.
The native approach in this ﬁeld of study was the inves-
tigation of a single MRI parameter at a time: (a) blood
oxygenation-level-dependent (BOLD) images, (b) anatom-
ical 3D T1-weighted images, (c) diﬀusion-weighted imaging
(DWI)/diﬀusion tensor imaging (DTI), and (d) quantitative
relaxometry.(a)ThecommonobservationinfunctionalMRI
studies is that increasing in the BOLD MRI signal represents
increasing of neural activity. Such a neurophysiological
“activation” results from elevated oxygen saturation levels
(and reduced paramagnetic deoxyhemoglobin contents) of
capillary and venous blood. These positive signal changes
are considered the basis for the functional organization
of the brain. (b) The T1-weighted sequence allows the
employment of several neuroanatomical techniques able to
describe and quantify macrostructural changes by using
probabilistic (voxel-based morphometry analysis) or quan-
titative research tools (manual/automatic region-of-interest
volumetry, cortical thickness measurements). (c) DWI and
DTI provide speciﬁc quantitative measurement of micro-
structural changes within white and gray matter compart-
ments. In particular DTI provides quantitative parameters,
such as the mean diﬀusivity that increases with microscopic
barrier disruption and extracellular ﬂuid accumulation and
the fractional anisotropy that provides information on the
microstructural integrity of highly oriented microstructures
(i.e., myelin). (d) Finally, another potential MRI technique
is the quantiﬁcation of mineral levels in the brain. MR
relaxometry is a sensitive method to evaluate the brain iron
contentinvivo.Ironaccumulationhasbeenimplicatedinthe
pathogenesis of many neurodegenerative diseases.
In the last ﬁve years, multimodal neuroimaging has
becamethemostpopularapproachtostudypathophysiology
of diseased brain. In fact, the aim of this ﬁeld of study is to
quantify the single or combined weight of MRI parameters
in describing neurodegenerative processes. In other words,
the possibility to measure MR parameters sensitive to com-
plementary tissue characteristics (e.g., volume atrophy, iron
deposition, and microstructural damage) could have great
potential for investigating pathological changes in several
neurologic/psychiatric diseases. At this moment, important
new ﬁndings have been reported although several issues
remain open. In this special edition, we have featured some
papers that address such issues.
The ﬁrst paper of this special edition is more forward-
looking. In fact, it presents a new experimental multimodal
MRI approach to better elucidate interrelated gray and white
matter changes in schizophrenic patients. This new method
represents a theoretical evolution of the previous and well-
known voxel-based analysis of T1-weighted images that
generally provides a mixed measure of neuronal “volume” or
“density.”
The second and third papers provide fundamental
overviews of recent ﬁndings about neurodegenerative pro-
cesses underlying Alzheimer’s disease (AD) and mild cog-
nitive impairments (MCIs) obtained through a multimodal
neuroimagingapproach.Thesubsequentpaperaddressesthe
speciﬁc advance in functional neuroimaging studies of AD
and MCI patients. All these papers highlight the importance
of multimodal neuroimaging in enhancing our ability to
diagnose MCI and AD in its early stages.2 Neurology Research International
Finally, the last two papers present the application of
advanced MRI measurements (automatic ROI volumetry,
cortical thickness measurements, and T2∗ iron quantiﬁ-
cation) to deﬁne the presence of new biomarkers able to
distinguishADpatientsfromnormalpressurehydrocephalus
and to improve the accurate diagnosis of suspect neurofer-
ritinopathy, a neurodegenerative disorder characterized by
the deposition of iron and ferritin in the brain.
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